A detailed history of Srs Capital Advisors, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 181 shares of CRL stock, worth $35,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181
Previous 135 34.07%
Holding current value
$35,434
Previous $27,000 29.63%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$187.96 - $245.29 $8,646 - $11,283
46 Added 34.07%
181 $35,000
Q2 2024

Aug 06, 2024

BUY
$206.39 - $268.73 $7,842 - $10,211
38 Added 39.18%
135 $27,000
Q1 2023

May 16, 2023

SELL
$191.89 - $259.92 $2,878 - $3,898
-15 Reduced 13.39%
97 $19,000
Q3 2022

Nov 03, 2022

SELL
$182.44 - $250.54 $9,122 - $12,527
-50 Reduced 30.86%
112 $22,000
Q2 2022

Aug 22, 2022

BUY
$204.13 - $302.4 $33,069 - $48,988
162 New
162 $35,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.